Combined with multiplex immunofluorescence, it revealed metabolically inactive tumor regions enriched in SFRP2+ CAFs and Tregs, forming immunosuppressive niches resistant to chemotherapy [126]. The gene discussed is SFRP2; the disease is neoplasm.